Study to Evaluate Laquinimod Compared to Interferon ß-1a Administered by Injection

Study Title

A Study to Evaluate 2 Doses Of Oral Administration Of Laquinimod Compared to Interferon ֳŸ-1a Administered by Injection in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)

Teva Identifier

LAQ-MS-306 | 2013-002082-19

ClinicalTrials.gov Identifier

NCT01975298

Study Status

Withdrawn

Trial Condition(s)

Relapsing Remitting Multiple Sclerosis

Interventions

Drug: Laquinimod | Drug: Avonexֲ®

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Click for participation criteria and map of study locations
neurology icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

18 Years to 55 Years

Trial Duration

01/01/2014 - 03/01/2014

Phase

Phase 3

Study Type

Interventional